Anti-PD-1/bacteria-emulating agent combination for advanced melanoma
This particular combination has been especially gratifying because not only does the SD-101 therapy drug induce tumour shrinkage at the actu
top of page
it's where dermatology lives
by John Evans
Jun 22, 20182 min read
Older patients respond better to melanoma immunotherapy
“Our study shows that age is an important factor to consider when administering immunotherapy to melanoma patients,” said Ashani Weeraratna,
by John Evans
Apr 13, 20182 min read
Macrophages impair PD-1 immunotherapy in melanoma
"Our study suggests that assessing the abundance of macrophages and the contextual presence of CD8 T-cells—for example by measuring gen
Derm City
Jan 12, 20182 min read
Anti-PD-1/PD-L1 therapy effective for desmoplastic melanoma
“Our findings challenge the previous school of thought that immunotherapy would offer little benefit to patients with desmoplastic melanoma
Featured Posts
bottom of page